The identification of the most effective HAART regimens in different clinical settings is still an issue. The aim of the study was to analyze how the compactness of HAART regimens is perceived and if differences between lamivudine (3TC) and emtricitabine (FTC) do exist according to a panel of Italian HIV/AIDS clinicians, using the Delphi method.
Maserati, R., Antinori, A., Bonora, S., Castagna, A., D'Arminio Monforte, A., De Luca, A., et al. (2014). Optimizing HIV therapy. A consensus project on differences between cytidine analogues and regime compactness. NEW MICROBIOLOGICA, 37(3), 285-306.
Optimizing HIV therapy. A consensus project on differences between cytidine analogues and regime compactness
PERNO, CARLO FEDERICO
2014-07-01
Abstract
The identification of the most effective HAART regimens in different clinical settings is still an issue. The aim of the study was to analyze how the compactness of HAART regimens is perceived and if differences between lamivudine (3TC) and emtricitabine (FTC) do exist according to a panel of Italian HIV/AIDS clinicians, using the Delphi method.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
2014_Optimizing HIV therapy. A consensus project on differences between cytidine_Maserati_NewMicrob.pdf
accesso aperto
Licenza:
Non specificato
Dimensione
212.19 kB
Formato
Adobe PDF
|
212.19 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
